ストックスクリーナーアプリを入手
0.00
100.00%
-1.71
アフターアワーズ：
2.16
2.16
+
Aptose Biosciences Inc (APTO) 最新ニュース
(APS) Equity Trading Insights (APS:CA) - news.stocktradersdaily.com
Aptose Announces Auditor Not Standing for Re-Appointment - The Manila Times
Aptose Biosciences Inc. - MENAFN.com
Stocks In Play: Aptose Biosciences Inc. - Barchart.com
Aptose Biosciences to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference - Nasdaq
Aptose to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference - The Manila Times
Aptose Biosciences announces change in accounting firm By Investing.com - Investing.com India
Aptose Biosciences announces change in accounting firm - Investing.com
(APS) Daily Stock Insights (APS:CA) - news.stocktradersdaily.com
Objective long/short (APS) Report (APS:CA) - news.stocktradersdaily.com
Aptose Biosciences (NASDAQ:APTO) Earns Sell Rating from Analysts at StockNews.com - Defense World
(APS) Technical Data (APS:CA) - news.stocktradersdaily.com
Aptose Biosciences (NASDAQ:APTO) Now Covered by StockNews.com - Defense World
Aptose Biosciences secures $25 million equity facility - MSN
Aptose Biosciences shares to delist from Nasdaq as of April 2 - Yahoo Finance
APTO stock touches 52-week low at $1.86 amid sharp annual decline - Investing.com Australia
APTO stock touches 52-week low at $1.86 amid sharp annual decline By Investing.com - Investing.com South Africa
Stock Market Shakes As Major Firms See Sharp Declines - Finimize
Nasdaq Surges 1%; US Construction Spending Rises In February - Benzinga
Why Aptose Biosciences (APTO) Stock Is Down Over 40% - Benzinga
Dow Dips Over 400 Points; ISM Manufacturing PMI Falls In March - Benzinga
Aptose Biosciences Says Shares to Be Delisted From Nasdaq - MarketScreener
Aptose Biosciences to be delisted from Nasdaq By Investing.com - Investing.com South Africa
Aptose Biosciences to be delisted from Nasdaq - Investing.com
Aptose Biosciences to Delist from Nasdaq in April - TipRanks
Aptose shares tumble following Nasdaq delisting decision By Investing.com - Investing.com Canada
Aptose Common Shares to Delist from Nasdaq as of April 2, 2025 - The Manila Times
Aptose Faces Nasdaq Exit: What This Means for Investors and Trading Options - Stock Titan
H.C. Wainwright raises Aptose stock target to $6, maintains Buy By Investing.com - Investing.com Canada
H.C. Wainwright raises Aptose stock target to $6, maintains Buy - Investing.com
Short Interest in Aptose Biosciences Inc. (NASDAQ:APTO) Drops By 56.6% - Defense World
HC Wainwright Forecasts Strong Price Appreciation for Aptose Biosciences (NASDAQ:APTO) Stock - Defense World
Aptose Biosciences price target raised to $6 from $2 at H.C. Wainwright - Yahoo Finance
Aptose Biosciences Inc. SEC 10-K Report - TradingView
Aptose Biosciences Advances AML Therapy and Strengthens Financial Position - TipRanks
Aptose Biosciences Brief: Adds Results to Date Highlight TUS Potential as an "Ideal" Third Drug to Include in AML Triplet Therapy - MarketScreener
Aptose Achieves Breakthrough in AML Treatment While Cutting Losses by 50% in 2024 - Stock Titan
Better Artificial Intelligence (AI) Stock: Nvidia vs. AMD - The Globe and Mail
Aptose Reports Year End 2024 Results and Corporate Highlights - The Manila Times
Aptose Biosciences (NASDAQ:APTO) Coverage Initiated at StockNews.com - Defense World
(APS) Strategic Market Analysis (APS:CA) - news.stocktradersdaily.com
3 Evergreen Financial Stocks to Buy With $3,000 and Hold Forever - The Globe and Mail
Bleichroeder LP Significantly Reduces Holdings in Aptose Biosciences Inc - GuruFocus
Aptose Biosciences Converts Debt to Equity with Hanmi Pharmaceutical By Investing.com - Investing.com South Africa
Aptose Biosciences Converts Debt to Equity with Hanmi Pharmaceutical - Investing.com
3 Reasons to Avoid DOX and 1 Stock to Buy Instead - The Globe and Mail
Bleichroeder LP Acquires Significant Stake in Aptose Biosciences Inc - GuruFocus.com
Trend Tracker for (APS) (APS:CA) - news.stocktradersdaily.com
0.24%
36.06%
大文字化:
|
ボリューム (24 時間):